- ►diabetesjournals.org VR Aroda, RR Henry - Diabetes Spectrum, 2003 - Am Diabetes Assoc The thiazolidinediones are a unique class of oral antidiabetic agents that has
been shown to directly reduce insulin resistance at sites of insulin action,
specifically adipose tissue, skeletal muscle, and the liver. By reducing ... Cited by 7 - Related articles - BL Direct - All 2 versions
F Wang, C Vergara, J Carabino, A Desilets, … - AMERICAN JOURNAL OF HEALTH SYSTEM …, 2004 - ASHP T hiazolidinediones are effective at achieving glycemic control in patients with
type 2 diabetes mellitus when used in combination therapy. However, this class
of insulin- sensitizing agents, which includes rosiglitazone maleate, ... Cited by 6 - Related articles - BL Direct - All 3 versions
[CITATION] for Study Group-Pioglitazone 001: The effects of pioglitazone on the lipid profile in patients …
G Boden - Current Opinion in Endocrinology, Diabetes and …, 2004 - journals.lww.com Introduction The increase in obesity in the United States has reached epidemic
proportions [1]. As obesity is usually associated with an increase in insulin
resistance, it is not surprising that there has been an equally dramatic ... Cited by 8 - Related articles - BL Direct - All 2 versions
Y Aso, K Okumura, N Yoshida, K Tayama, Y … - Experimental and Clinical Endocrinology and Diabetes, 2004 - thieme-connect.com Impaired fibrinolysis in type 2 diabetes may be caused by an increased plasma
concentration of plasminogen activator inhibitor 1 (PAI-1), although the effects
of short-term hypoglycemic therapy on fibrinolytic activity are poorly ... Cited by 12 - Related articles - BL Direct - All 4 versions
M Sekiguchi, M Kurabayashi, H Adachi, H … - The American journal of cardiology, 2004 - Elsevier Restenosis after coronary stent placement occurs in 16% to 38% of patients with
coronary artery disease and remains a serious clinical problem.[1 and 2] Insulin
resistance is widely known to be 1 of the risk factors for ... Cited by 14 - Related articles - All 8 versions
F Pharmacotherapy - medscape.com Clinical data suggest that thiazolidinediones—specifically, rosiglitazone and
pioglitazone—may improve cardiovascular risk factors through multiple
mechanisms. Low insulin sensitivity has been described as an independent ... Related articles
P FISIOTERAPIA - unimep.br Page 1. UNIVERSIDADE METODISTA DE PIRACICABA FACULDADE DE CIÊNCIAS DA SAÚDE
PROGRAMA DE PÓS-GRADUAÇÃO EM FISIOTERAPIA “UTILIZAÇÃO ... Related articles - All 2 versions
REL PharmD, DK PharmD - Progress in Cardiovascular Nursing - interscience.wiley.com The incidence of obesity and type 2 diabetes mellitus (DM2) in the United States
has been increasing dramatically over the past 15 years, and is now at epidemic
proportions. DM2 is the clinical manifestation of a long-term metabolic ... Related articles - BL Direct - All 3 versions
H Failure, T Use - medscape.com Clinical data suggest that thiazolidinediones-specifically, rosiglitazone and
pioglitazone-may improve cardiovascular risk factors through multiple
mechanisms. Low insulin sensitivity has been described as an independent ... Related articles - All 4 versions
